BSX Q3 2025 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5.1B+20.3% YoY

Gross Profit

$3.5B69.9% margin

Operating Income

$1.1B20.7% margin

Net Income

$755M14.9% margin

EPS (Diluted)

$0.50

QoQ Revenue Growth

+0.1%

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$1.2B

Stock-Based Comp.

$79M

Balance Sheet

Total Assets

$42.7B

Total Liabilities

$19.1B

Stockholders' Equity

$23.4B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.1B	$4.2B	+20.3%
Gross Profit	$3.5B	$2.6B	+33.8%
Operating Income	$1.1B	$674M	+55.8%
Net Income	$755M	$469M	+61.0%

Revenue Segments

Cardiovascular

$3.3B66%

MedSurg

$1.7B34%

Geographic Segments

UNITED STATES

$2.1B54%

Non-US

$1.8B46%